ask="N/A"
ask_size="N/A"
average_daily_volume="2454420"
bid="N/A"
bid_size="N/A"
book_value="-0.1510"
change="-0.0078"
change_from_200_day_moving_average="0.0878"
change_from_50_day_moving_average="0.2001"
change_from_52_week_high="-0.3478"
change_From_52_week_low="0.3522"
change_in_percent="-1.2581%"
close="0.6122"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.4640"
ebitda="-30.10M"
eps_estimate_current_year="-0.3800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.2700"
ex_dividend_date="N/A"
float_shares="71947000"
high="0.6350"
high_52_weeks="0.9600"
last_trade_date="1/30/2017"
last_trade_price="0.6122"
last_trade_size="3300"
last_trade_time="4:45pm"
low="0.6000"
low_52_weeks="0.2600"
market_capitalization="61.11M"
moving_average_200_day="0.5244"
moving_average_50_day="0.4121"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.6000"
open="0.6199"
pe_ratio="1.3194"
peg_ratio="-0.0600"
percent_change_from_200_day_moving_average="+16.7454%"
percent_change_from_50_day_moving_average="+48.5486%"
percent_change_from_52_week_high="-36.2292%"
percent_change_from_52_week_low="+135.4615%"
previous_close="0.6200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="8.6947"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.1100"
stock_exchange="ASE"
symbol="PLX"
volume="2981285"
weeks_range_52="0.2600 - 0.9600"
